HealthEquity CCO Michael Fiore terminated without cause, effective Oct 5, 2026; no successor named
HEALTHEQUITY, INC.
Michael Fiore, Chief Commercial Officer of HealthEquity, was terminated by the company without cause, effective October 5, 2026.
The Chief Commercial Officer responsibilities will be redistributed to other members of HealthEquity's management team; no replacement was named.
Fiore will receive previously negotiated severance payments and benefits under his employment agreement, as detailed in the company's proxy statement filed May 13, 2026.
Severance is conditioned on a release of claims against the company and continued compliance with restrictive covenants in his employment agreement.
Outstanding equity awards will be treated consistent with HealthEquity's 2014 and 2024 Stock Incentive Plans and his applicable award agreements.
The employment of Michael Fiore, the Chief Commercial Officer at HealthEquity, Inc. (the “Company”), was terminated by the Company without cause, effective October 5, 2026.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.97
Michael Fiore was terminated as Chief Commercial Officer at HEALTHEQUITY, INC..
Action
terminated
Role
Chief Commercial Officer
Exact text from the filing
The employment of Michael Fiore, the Chief Commercial Officer at HealthEquity, Inc. (the “Company”), was terminated by the Company without cause, effective October 5, 2026.
This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.